Palo Alto Investors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Palo Alto Investors’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-390,800	Closed	-$9.42M	–	31
2023 Q1	$9.42M	Hold	390,800	–	–	0.78%	16
2022 Q4	$4.13M	Hold	390,800	–	–	0.35%	20
2022 Q3	$1.76M	Buy	+390,800	New	+$1.78M	0.14%	25

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Palo Alto Investors's PRVB Position: Q2 2023 in Review

Palo Alto Investors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 390,800 shares — an estimated $9.42M sold.

Palo Alto Investors first reported a position in PRVB in Q3 2022 and held it in 3 quarters. The position peaked at $9.42M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Palo Alto Investors reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Palo Alto Investors sold 390,800 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $9.42M.
Palo Alto Investors first reported a position in Provention Bio, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Palo Alto Investors's Provention Bio, Inc. Common Stock position peaked at $9.42M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Palo Alto Investors's 13F filing for Q2 2023, filed 14 Aug 2023.